ID   LANEL_STAEP             Reviewed;          55 AA.
AC   Q57312;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-AUG-2020, entry version 39.
DE   RecName: Full=Lantibiotic epilancin;
DE   Flags: Precursor;
GN   Name=elkA;
OS   Staphylococcus epidermidis.
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=1282;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 25-55, AND
RP   DEHYDRATION AT SER-27; THR-31; SER-32 AND THR-52.
RC   STRAIN=K7;
RX   PubMed=7607233; DOI=10.1111/j.1432-1033.1995.tb20600.x;
RA   Van de Kamp M., Van den Hooven H.W., Konings R.N.H., Bierbaum G.,
RA   Sahl H.-G., Kuipers O.P., Siezen R.J., de Vos W.M., Hilbers C.W.,
RA   Van de Ven F.J.M.;
RT   "Elucidation of the primary structure of the lantibiotic epilancin K7 from
RT   Staphylococcus epidermidis K7. Cloning and characterisation of the
RT   epilancin-K7-encoding gene and NMR analysis of mature epilancin K7.";
RL   Eur. J. Biochem. 230:587-600(1995).
CC   -!- FUNCTION: Lanthionine-containing peptide antibiotic (lantibiotic)
CC       active on Gram-positive bacteria such as staphylococci, enterococci and
CC       streptococci (By similarity). The bactericidal activity of lantibiotics
CC       is based on depolarization of energized bacterial cytoplasmic
CC       membranes, initiated by the formation of aqueous transmembrane pores
CC       (By similarity). {ECO:0000250|UniProtKB:P86047}.
CC   -!- PTM: Maturation of this lantibiotic involves the enzymatic conversion
CC       of Thr, and Ser into dehydrated AA by ElxB and the formation of
CC       thioether bonds with cysteine by the cyclase ElxC (By similarity). The
CC       next steps are cleavage of the leader peptide by ElxP and membrane
CC       translocation by ElxT (By similarity). The leader peptide may be
CC       removed before membrane translocation, in contrast to other
CC       lantibiotics for which the cleavage occur after translocation (By
CC       similarity). This is suggested by the probable cytoplasmic localization
CC       of the serine protease ElxP that cleaves the leader peptide (By
CC       similarity). {ECO:0000250|UniProtKB:P86047}.
CC   -!- PTM: It is not established whether the 2,3-didehydrobutyrine is the
CC       E- or Z-isomer. {ECO:0000269|PubMed:7607233}.
CC   -!- PTM: The N-terminal D-lactate is probably produced by dehydration of
CC       Ser-25 by ElxB, followed by proteolytic removal of the leader peptide
CC       by the serine protease ElxP and hydrolysis of the resulting new N-
CC       terminal dehydroalanine (By similarity). This hydrolysis may occur
CC       spontaneously (Probable). The pyruvate group thus formed is reduced to
CC       D-lactate by the NADPH-dependent oxidoreductase ElxO (By similarity).
CC       This N-terminal D-lactate protects the lantibiotic against degradation
CC       against aminopeptidase (By similarity). {ECO:0000250|UniProtKB:P86047,
CC       ECO:0000305|PubMed:7607233}.
CC   -!- SIMILARITY: Belongs to the type A lantibiotic family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X87412; CAA60860.1; -; Genomic_DNA.
DR   EMBL; U20348; AAA79236.1; -; Genomic_DNA.
DR   PIR; S65681; S65681.
DR   SMR; Q57312; -.
DR   TCDB; 1.C.20.1.7; the nisin (nisin) family.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:UniProtKB-KW.
DR   GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial; Bacteriocin; D-amino acid;
KW   Direct protein sequencing; Lantibiotic; Thioether bond.
FT   PROPEP          1..24
FT                   /note="Cleaved by ElxP"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT                   /id="PRO_0000275927"
FT   PEPTIDE         25..55
FT                   /note="Lantibiotic epilancin"
FT                   /evidence="ECO:0000269|PubMed:7607233"
FT                   /id="PRO_0000275928"
FT   MOD_RES         25
FT                   /note="D-lactate; by the dehydratase ElxB and the
FT                   dehydrogenase ElxO"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT   MOD_RES         27
FT                   /note="2,3-didehydroalanine (Ser); by the dehydratase ElxB"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT   MOD_RES         31
FT                   /note="2,3-didehydrobutyrine; by the dehydratase ElxB"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT   MOD_RES         32
FT                   /note="2,3-didehydroalanine (Ser); by the dehydratase ElxB"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT   MOD_RES         52
FT                   /note="2,3-didehydrobutyrine; by the dehydratase ElxB"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT   CROSSLNK        36..40
FT                   /note="Lanthionine (Ser-Cys); by the dehydratase ElxB and
FT                   the cyclase ElxC"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT   CROSSLNK        44..47
FT                   /note="Beta-methyllanthionine (Thr-Cys); by the dehydratase
FT                   ElxB and the cyclase ElxC"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
FT   CROSSLNK        46..49
FT                   /note="Beta-methyllanthionine (Thr-Cys); by the dehydratase
FT                   ElxB and the cyclase ElxC"
FT                   /evidence="ECO:0000250|UniProtKB:P86047,
FT                   ECO:0000269|PubMed:7607233"
SQ   SEQUENCE   55 AA;  5851 MW;  28311B7C49951D7C CRC64;
     MNNSLFDLNL NKGVETQKSD LSPQSASVLK TSIKVSKKYC KGVTLTCGCN ITGGK
//
